Advanced search
Publication Cover
Hematology Volume 28, 2023 - Issue 1
Submit an article Journal homepage
819
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Detection of transient abnormal myelopoiesis blasts in a liver biopsy specimen by double-immunostaining for full-length GATA1 and CD42b

Azusa Habaa Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu, JapanView further author information
,
Yuko Imaizumib Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, JapanView further author information
,
Daichi Hayashia Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu, JapanView further author information
,
Shiho Yasuea Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu, JapanView further author information
,
Hiroki Otsukaa Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu, JapanView further author information
,
Saori Endoa Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu, JapanView further author information
,
Michio Ozekia Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu, JapanCorrespondence[email protected]
View further author information
,
Kazuhiro Kobayashic Department of Diagnostic Pathology, Gifu University Hospital, Gifu, JapanView further author information
,
Tatsuhiko Miyazakic Department of Diagnostic Pathology, Gifu University Hospital, Gifu, JapanView further author information
,
Akira Harab Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, JapanView further author information
&
Hidenori Ohnishia Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu, JapanView further author information
 show all
Article: 2240135 | Received 09 May 2023, Accepted 19 Jul 2023, Published online: 25 Jul 2023

References

  • Watanabe K. Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome. Pediatr Int. 2019 Mar;61(3):222–229. doi:10.1111/ped.13776. Epub 2019 Mar 4. PMID: 30593694.
  • Massey GV, Zipursky A, Chang MN, et al. Weinstein HJ; children’s oncology group (COG). A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): children’s oncology group (COG) study POG-9481. Blood. 2006 Jun 15;107(12):4606–4613. doi:10.1182/blood-2005-06-2448. Epub 2006 Feb 9. PMID: 16469874.
  • Klusmann JH, Creutzig U, Zimmermann M, et al. Treatment and prognostic impact of transient leukemia in neonates with Down syndrome. Blood. 2008 Mar 15;111(6):2991–2998. doi:10.1182/blood-2007-10-118810. Epub 2008 Jan 8. PMID: 18182574; PMCID: PMC2265448.
  • Muramatsu H, Kato K, Watanabe N, et al. Risk factors for early death in neonates with Down syndrome and transient leukaemia. Br J Haematol. 2008 Aug;142(4):610–615. doi:10.1111/j.1365-2141.2008.07231.x. Epub 2008 May 28. PMID: 18510680.
  • Gamis AS, Alonzo TA, Gerbing RB, et al. Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the children’s oncology group study A2971. Blood. 2011 Dec 22;118(26):6752–6759; quiz 6996. doi:10.1182/blood-2011-04-350017. Epub 2011 Aug 17. PMID: 21849481; PMCID: PMC3245202.
  • Tunstall O, Bhatnagar N, James B, et al. Wright M; British society for haematology. guidelines for the investigation and management of transient leukaemia of Down syndrome. Br J Haematol. 2018 Jul;182(2):200–211. doi:10.1111/bjh.15390. Epub 2018 Jun 19. PMID: 29916557.
  • Lee WY, Weinberg OK, Evans AG, et al. Loss of full-length GATA1 expression in megakaryocytes is a sensitive and specific immunohistochemical marker for the diagnosis of myeloid proliferative disorder related to Down syndrome. Am J Clin Pathol. 2018 Mar 7;149(4):300–309. doi:10.1093/ajcp/aqy001. PMID: 29481579; PMCID: PMC5848381.
  • Lee WY, Weinberg OK, Pinkus GS. GATA1 is a sensitive and specific nuclear marker for erythroid and megakaryocytic lineages. Am J Clin Pathol. 2017 Apr 1;147(4):420–426. doi:10.1093/ajcp/aqx018. PMID: 28340113; PMCID: PMC5848378.
  • Park MJ, Sotomatsu M, Ohki K, et al. Liver disease is frequently observed in Down syndrome patients with transient abnormal myelopoiesis. Int J Hematol. 2014 Feb;99(2):154–161. doi:10.1007/s12185-013-1487-5. Epub 2013 Dec 14. PMID: 24338744.
  • Hattori H, Matsuzaki A, Suminoe A, et al. High expression of platelet-derived growth factor and transforming growth factor-beta 1 in blast cells from patients with Down syndrome suffering from transient myeloproliferative disorder and organ fibrosis. Br J Haematol. 2001 Nov;115(2):472–475. doi:10.1046/j.1365-2141.2001.03093.x. PMID: 11703351.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.